 |
 |
PRODUCT PROFILE
Latest Dublin Prices
Bayer get US approval for cancer drug
Thursday, September 27 16:24:23
The U.S. Food and Drug Administration today approved a new drug for advanced colon cancer developed by Bayer AG a month ahead of the agency's expected action date for a decision on the medicine.
The drug, to be sold under the brand name Stivarga, was approved to treat colon cancer that has progressed after prior treatment or has spread to other parts of the body, the agency said.
In pivotal clinical trials, Stivarga -- known chemically as regorafenib -- helped patients live on average 1.4 months longer than those who received standard treatment without the Bayer drug. (C ) Reuters
Business World is a service of Media World Ltd. All rights reserved. While every effort has been made to ensure the accuracy of the data provided, neither Media World Ltd nor its agents or representatives will be responsible for any loss or damage on the part of users however caused. The service is for entertainment only, and no decisions, particularly investment decisions, should be taken on the basis of information supplied in the service.